Naxim (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Naxim, is a mucolytic presented as an oral formulation for inhalation and oral use. It helps reduce mucus viscosity and supports expectoration in patients with respiratory tract infections.\n\nGNH India supplies Naxim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ambroxol Hydrochloride acts on the respiratory tract to facilitate mucus clearance and relieve cough.\n\nCough associated with acute respiratory infections: improves expectoration and reduces cough frequency.\nBronchitis: decreases mucus thickness, aiding airway patency.\nMucus hypersecretion: lowers viscosity of secretions, supporting mucociliary transport.

Adverse reactions may occur with ambroxol use.\n\nCommon Side Effects:\n- Taste disturbance (e.g., bitter or metallic taste)\n- Nausea or vomiting\n- Abdominal discomfort or dyspepsia\n- Headache\n- Mild skin rash or pruritus\n\nSerious or Rare Side Effects:\n- Allergic reactions such as urticaria or angioedema\n- Severe skin reactions (e.g., Stevens‑Johnson syndrome)\n- Hepatic enzyme elevation or hepatitis\n- Bronchospasm, especially in asthmatic patients\n- Anaphylactic shock

Use ambroxol with attention to patient‑specific factors and storage conditions.\n\nAssess renal function: adjust use in patients with severe renal impairment.\nMonitor for allergic reactions: discontinue if signs of hypersensitivity appear.\nUse with caution in asthma: observe for bronchospasm.\nAvoid in known hypersensitivity to ambroxol or similar compounds.\nStore at room temperature: keep in the original container, protect from moisture and direct sunlight.

Ambroxol may interact with other medicines that affect cough reflex or mucosal irritation.\n\nMajor Interactions (Avoid):\n- Antitussive agents (e.g., codeine) that suppress cough reflex\n- Concurrent use of other mucolytics, which may increase irritation\n- Duplicate ambroxol‑containing products, leading to excess exposure\n\nModerate Interactions (Monitor Closely):\n- Beta‑adrenergic blockers: may blunt bronchodilatory effect\n- Non‑steroidal anti‑inflammatory drugs: monitor for gastrointestinal irritation\n- Antihistamines: observe for additive sedation or dry‑mouth effects